Tag Archives: Oral

Oral sex linked to mouth cancer

Having lots of oral sex at a young age can increase the risk of mouth cancer, experts have warned. People who have had ten or more oral sex partners were found to be 4.3 times more likely to develop the disease, research showed. Researchers also found the risk of human papillomavirus (HPV)-related mouth and throat… Read More »

What are the oral medications for diabetes

Why does diet matter after bariatric surgery? Each class of medicine works in different ways to lower blood sugar. Conquer heart disease in 10 min. GLP-1 analogs resulted in weight loss and had more gastrointestinal side-effects, while in general DPP-4 inhibitors were weight-neutral and increased risk for infection and headache, but both classes appear to… Read More »

How much is oral acne medication

It is a topical treatment so it gets to work on the skin how much is oral acne medication fast. Oral medications, taken by mouth and sometimes called systemic medications, work internally to improve the skin. If it continues beyond that, you will want to inform your doctor as soon as possible. A pregnancy test… Read More »

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis Print this page NORTH CHICAGO, Ill., Aug. 16, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), a 15 mg, once-daily oral… Read More »

FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease

Print this page SUMMIT, N.J.–(BUSINESS WIRE) July 19, 2019 — Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. Otezla, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the… Read More »